News

Johns Hopkins symposium will highlight new challenges and approaches in the fight against the mosquito-borne disease.

Ben Berkhout, PhD, discusses if CRISPR/Cas9 will be a new antiviral strategy for the eradication of HIV.

Here are the top takeaways from the European Congress of Clinical Microbiology and Infectious Disease 2019 meeting.

Thus far, 626 cases of measles have been recorded in 2019 and health officials anticipate that case counts will soon surge past the record of 667 cases documented during all of 2014.

Medical Economics report finds just 22% of physicians reported a rise in compensation during 2018.

A new study may help to explain how bacteria present at low levels in healthy human mouths can persist for months and cause hospital outbreaks of drug-resistant infections.

At ECCMID 2019, László Majoros, MD, PhD, spoke about rezafungin’s activity against common and rare Candida species in vitro.

A new strategy that enforces a type of cell division in memory T cells could lead to longer-lasting immune protection in patients.

Missing visits is a warning sign that patients may discontinue PrEP, according to a recent study that found only 38% of participants remained in treatment over 12 months.

Madeline King, PharmD, discusses her research presented at ECCMID 2019 on pre-operative asymptomatic bacteriuria and appropriateness of aztreonam usage.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of April 14, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A new look into pediatric telemedicine prescribing shows some concerning revelations about prescribing patterns.

Sexual risk behavior was significantly lower among men in community supervision programs who participated in couples-based intervention, in a recent study.

Following a 2018 outbreak in the US of acute flaccid myelitis, a new paper calls for research into the causes of this surge of a usually rare disease.

In a new trial, an experimental antibody suppressed HIV in patients on short-term pause from their daily antiretroviral therapy regimens.

The Early Sepsis Indicator is hematology-based cellular biomarker designed to help emergency department physicians identify patients with sepsis or at an increased risk of developing sepsis.

This In the Literature piece details a study evaluating the effects of ID consultation for OPAT patients.

A study using monkeys provides an intriguing glimpse of the possibilities of using CRISPR gene editing technology to knock out HIV reserves in humans.

A shortage of infectious disease physicians should have us all concerned and here's why.

Could an additive in your food be messing with the immune process that helps you fight off the flu after receiving the influenza vaccine?

Open Forum Infectious Disease study highlights workplace issues within the specialty.

Will biomarker-guided specific therapies the best option for treating sepsis in the future?

During a year-long study, 80 electronic conversational comments were made using the stewardship team’s audit-and-feedback tool and recommendations were fully adopted 90% of the time.

Oral ibrexafungerp demonstrates a favorable therapeutic response in patients with difficult-to-treat Candida infections, including those caused by non-albicans Candida species.

Lefamulin demonstrated non-inferiority when compared with moxifloxacin, and both treatment arms reported a low rate of serious treatment-emergent AEs or treatment-emergent AEs leading to discontinuation.

Cidara Therapeutics has developed CB-012, a stable conjugate of a highly potent antiviral agent linked to human IgG1 Fc, and investigators are evaluating the asset for the treatment and prevention of seasonal and pandemic influenza A and B infections.